EP4512809A4 - Verfahren zur herstellung eines 7h-pyrrolo[2,3-d pyrimidin-4-aminderivats - Google Patents

Verfahren zur herstellung eines 7h-pyrrolo[2,3-d pyrimidin-4-aminderivats

Info

Publication number
EP4512809A4
EP4512809A4 EP23791952.7A EP23791952A EP4512809A4 EP 4512809 A4 EP4512809 A4 EP 4512809A4 EP 23791952 A EP23791952 A EP 23791952A EP 4512809 A4 EP4512809 A4 EP 4512809A4
Authority
EP
European Patent Office
Prior art keywords
pyrrolo
pyrimidine
preparation
amine derivative
amine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP23791952.7A
Other languages
English (en)
French (fr)
Other versions
EP4512809A1 (de
Inventor
Daisuke Takeda
Katsumasa Nonoshita
Yu KOBAYAKAWA
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taiho Pharmaceutical Co Ltd
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Publication of EP4512809A1 publication Critical patent/EP4512809A1/de
Publication of EP4512809A4 publication Critical patent/EP4512809A4/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Epidemiology (AREA)
EP23791952.7A 2022-04-22 2023-04-21 Verfahren zur herstellung eines 7h-pyrrolo[2,3-d pyrimidin-4-aminderivats Pending EP4512809A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2022071155 2022-04-22
PCT/JP2023/015917 WO2023204304A1 (ja) 2022-04-22 2023-04-21 ７Ｈ－ピロロ［２，３－ｄ］ピリミジン－４－アミン誘導体の製造方法

Publications (2)

Publication Number Publication Date
EP4512809A1 EP4512809A1 (de) 2025-02-26
EP4512809A4 true EP4512809A4 (de) 2026-04-22

Family

ID=88420051

Family Applications (1)

Application Number Title Priority Date Filing Date
EP23791952.7A Pending EP4512809A4 (de) 2022-04-22 2023-04-21 Verfahren zur herstellung eines 7h-pyrrolo[2,3-d pyrimidin-4-aminderivats

Country Status (10)

Country Link
US (1) US20250270214A1 (de)
EP (1) EP4512809A4 (de)
JP (1) JPWO2023204304A1 (de)
KR (1) KR20250005303A (de)
CN (1) CN119053605A (de)
AU (1) AU2023257102A1 (de)
CA (1) CA3250005A1 (de)
MX (1) MX2024012990A (de)
TW (1) TW202400139A (de)
WO (1) WO2023204304A1 (de)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3925669A1 (de) * 2019-02-15 2021-12-22 Taiho Pharmaceutical Co., Ltd. 7h-pyrrolo[2,3-d]pyrimidin-4-amin-derivat

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7326516B2 (ja) 2017-04-18 2023-08-15 花王株式会社 外用薬

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3925669A1 (de) * 2019-02-15 2021-12-22 Taiho Pharmaceutical Co., Ltd. 7h-pyrrolo[2,3-d]pyrimidin-4-amin-derivat

Also Published As

Publication number Publication date
KR20250005303A (ko) 2025-01-09
MX2024012990A (es) 2024-11-08
WO2023204304A1 (ja) 2023-10-26
CA3250005A1 (en) 2025-06-17
US20250270214A1 (en) 2025-08-28
JPWO2023204304A1 (de) 2023-10-26
TW202400139A (zh) 2024-01-01
EP4512809A1 (de) 2025-02-26
AU2023257102A1 (en) 2024-12-05
CN119053605A (zh) 2024-11-29

Similar Documents

Publication Publication Date Title
EP4493561A4 (de) Verfahren zur herstellung substituierter spirooxindolderivate
EP4268978A4 (de) Verfahren zur herstellung eines laminats
EP4206205C0 (de) Verfahren zur herstellung einer pyrrolopyrimidinverbindung
EP4407078A4 (de) Verfahren zur herstellung eines verbundsubstrats
EP4471935A4 (de) Verfahren zur herstellung eines sulfidbasierten festelektrolyts
EP4378664C0 (de) Verfahren zur herstellung dreidimensionaler formkörper
EP4417325A4 (de) Verfahren zur herstellung eines mehrschichtigen körpers
DE60322763D1 (de) Verfahren zur Herstellung eines Pulvers mit hohem Gerbstoffgehalt
EP4471811A4 (de) Verfahren zur herstellung eines sulfidbasierten festelektrolyts
EP4512809A4 (de) Verfahren zur herstellung eines 7h-pyrrolo[2,3-d pyrimidin-4-aminderivats
EP3960929C0 (de) Verfahren zur herstellung eines kunstrasens
EP4484029A4 (de) Verfahren zur herstellung eines geschichteten heissprägeformkörpers
EP4411028C0 (de) Verfahren zur herstellung eines mehrschichtigen beta-ga2o3/beta-ga2o3-körpers
EP4424451A4 (de) Verfahren zur herstellung eines verbundenen körpers
EP3984982A4 (de) Verfahren zur herstellung eines morphinan-derivats
EP4142519C0 (de) Verfahren zur herstellung eines aromastoffes
EP4495165A4 (de) Verfahren zur herstellung eines polyethylenglykolderivats
EP4372062A4 (de) Verfahren zur herstellung eines verbundenen körpers
EP4349777A4 (de) Verfahren zur herstellung eines sulfidbasierten festelektrolyts
EP4458918A4 (de) Verfahren zur herstellung eines verbundenen körpers
EP4512808A4 (de) Kristall eines 7h-pyrrolo[2,3-d pyrimidin-4-aminderivats
EP4505877A4 (de) Verfahren zur herstellung eines getränks
EP4410254A4 (de) Verfahren zur herstellung eines saugfähigen artikels
EP4503103A4 (de) Verfahren zur herstellung eines gebundenen körpers
EP4245508C0 (de) Verfahren zur herstellung eines verbundartikels

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20241114

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR

A4 Supplementary search report drawn up and despatched

Effective date: 20260323

RIC1 Information provided on ipc code assigned before grant

Ipc: C07D 487/04 20060101AFI20260317BHEP

Ipc: A61K 31/519 20060101ALI20260317BHEP

Ipc: A61P 35/00 20060101ALI20260317BHEP

Ipc: A61P 35/02 20060101ALI20260317BHEP